Announcement on the Resignation of Core Technical Personnel
Filed with SSE · · 3 pages · Chinese
Kexing Biopharm Co., Ltd. on 6ix
Earlier from Kexing Biopharm
- Beyond Horizons, Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026
- Announcement on the Achievements of Vesting Conditions in the 2nd Vesting Period of the 2024 Restricted Stock Incentive Plan
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of GB10 for Injection
- Announcement on Resolutions of the 2025 Annual General Meeting
Later from Kexing Biopharm
- SHAN DONG KEXING BIOPRODUCTS CO., LTD.: Announcement on Granting of Restricted Stocks to Incentive Objects
- SHAN DONG KEXING BIOPRODUCTS CO., LTD.: Announcement on Vesting Results for the 2nd Vesting Period under the 2024 Restricted Stock Incentive Plan and the Listing of Shares
- SHAN DONG KEXING BIOPRODUCTS CO., LTD.: Announcement on Change of Sponsor Representative for Continuous Supervision
- SHAN DONG KEXING BIOPRODUCTS CO., LTD.: Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- SHAN DONG KEXING BIOPRODUCTS CO., LTD.: Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
Follow Kexing Biopharm into a list and get an email when it puts out news.
Follow Kexing Biopharm